Home›Companies›Biotech & Pharma›Watershed Medical

Watershed Medical Inc.

Develops drug treatments for people with bladder cancer.

Updated Nov 10, 2026·Latest SEC filing Apr 14, 2026·Suggest an edit

About Watershed Medical

Watershed Medical is a private company based in Bellevue, Washington, incorporated in 2025 in Delaware. It has reported $300,000 raised in one offering on Form D since April 2026. Its chief executive is Christopher KInsella.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 31, 2026Apr 14, 2026$300,000of $10.0M target3$100KEquityRule 506(c)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Watershed Medical's Form D filed Apr 14, 2026.

CK
Christopher KInsella
Chief Executive Officer

Sources

  1. SECWatershed Medical Inc. filing history
  2. CompanyWatershed Medical contact